Drug intelligence / Profile preview

i-Nelita

Development stage
Unknown
Lead developer
Steadfast Medishield
Modality
Recombinant Proteins and Enzymes, Small Molecules
01

Overview

i-Nelita is a specialized renal nutrition supplement developed and marketed by Steadfast Medishield (now Steadfast Limited) for the dietary management of patients with chronic kidney disease (CKD). Formulated as an oral sachet, it typically contains a comprehensive blend of high-quality whey protein, essential amino acids, vitamins, and minerals. The product is specifically designed to provide nutritional support for patients, particularly those undergoing dialysis who are at high risk of protein-energy wasting (PEW). By supplying essential building blocks for protein synthesis in a kidney-friendly formulation, i-Nelita helps maintain nutritional status and a positive nitrogen balance while minimizing the accumulation of metabolic waste products that the kidneys can no longer effectively filter. It is used as part of a broader renal care regimen to improve the overall health and quality of life of patients with impaired renal function.

Brand names
i-NelitaNelita

Beyond the preview

Go deeper on i-Nelita.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-Nelita.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call